Typical acute promyelocytic leukemia (APL) is associated with the t(15;17) translocation, expression of a PML/RARA fusion transcript, and responsiveness to all-trans retinoic acid (ATRA). Rare APL cases implicating the RARA but not the PML gene have been reported. Cases with t(11;17)(q23;q21) which fuses the PLZF and RARA genes do not respond to ATRA. In contrast, cases with t(11;17)(q13;q21) and t(5;17)(q35;q21) which fuse RARA with NuMA and NPM, respectively, were reported to be sensitive to ATRA. We described previously an APL case with an unbalanced t(5;17) implicating RARA but neither PML nor PLZF. Here, we show that in this case: (1) the NPM gene is not involved, as demonstrated by RT-PCR and Southern blot; (2) response to ATRA in vitro is atypical, as demonstrated by morphological and functional maturation assays; and (3) PML nuclear bodies are not disrupted, as evidenced by immunofluorescence staining.

Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia / M. J. Mozziconacci, C. Liberatore, F. Grignani, D. Sainty, P. G. Pelicci, F. Birg, M. Lafage-Pochitaloff. - In: LEUKEMIA. - ISSN 0887-6924. - 13:6(1999 Jun), pp. 862-8-868. [10.1038/sj.leu.2401412]

Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia

P.G. Pelicci;
1999

Abstract

Typical acute promyelocytic leukemia (APL) is associated with the t(15;17) translocation, expression of a PML/RARA fusion transcript, and responsiveness to all-trans retinoic acid (ATRA). Rare APL cases implicating the RARA but not the PML gene have been reported. Cases with t(11;17)(q23;q21) which fuses the PLZF and RARA genes do not respond to ATRA. In contrast, cases with t(11;17)(q13;q21) and t(5;17)(q35;q21) which fuse RARA with NuMA and NPM, respectively, were reported to be sensitive to ATRA. We described previously an APL case with an unbalanced t(5;17) implicating RARA but neither PML nor PLZF. Here, we show that in this case: (1) the NPM gene is not involved, as demonstrated by RT-PCR and Southern blot; (2) response to ATRA in vitro is atypical, as demonstrated by morphological and functional maturation assays; and (3) PML nuclear bodies are not disrupted, as evidenced by immunofluorescence staining.
Chromosomes, Human, Pair 17; Antineoplastic Agents; Humans; Aged; Recombinant Fusion Proteins; Cell Nucleus; Translocation, Genetic; Chromosomes, Human, Pair 5; Receptors, Retinoic Acid; Tumor Cells, Cultured; Leukemia, Promyelocytic, Acute; Tretinoin; Fluorescent Antibody Technique; Female
Settore MED/04 - Patologia Generale
giu-1999
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/195241
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 6
social impact